Clinical trial
A Monitor System for the Safety of Dabigatran Anticoagulation Treatment in Nonvalvular Atrial Fibrillation
NCT02414035 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Monitor System for the Safety of Dabigatran Anticoagulation Treatment in Nonvalvular Atrial Fibrillation
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 22, 2015
- Completion date
- April 18, 2018
- Enrollment
- 1,496 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.